BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31870114)

  • 1. The Role of Stem Cell Factor in Hyperpigmented Skin Lesions.
    Atef A; El-Rashidy MA; Abdel Azeem A; Kabel AM
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3723-3728. PubMed ID: 31870114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
    Liu-Smith F; Jia J; Zheng Y
    Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
    Sabet MN; Rakhshan A; Erfani E; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation.
    Yun CY; Roh E; Kim SH; Han J; Lee J; Jung DE; Kim GH; Jung SH; Cho WJ; Han SB; Kim Y
    Theranostics; 2020; 10(1):340-352. PubMed ID: 31903124
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
    De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
    Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-histochemical evaluation of solar lentigines: The association of KGF/KGFR and other factors with lesion development.
    Lin CB; Hu Y; Rossetti D; Chen N; David C; Slominski A; Seiberg M
    J Dermatol Sci; 2010 Aug; 59(2):91-7. PubMed ID: 20620021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane.
    Torres-Álvarez B; Mesa-Garza IG; Castanedo-Cázares JP; Fuentes-Ahumada C; Oros-Ovalle C; Navarrete-Solis J; Moncada B
    Am J Dermatopathol; 2011 May; 33(3):291-5. PubMed ID: 21317614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolocalization of glioma-associated oncogene homolog 1 in non melanoma skin cancer.
    Bakry OA; Samaka RM; Shoeib MA; Megahed DM
    Ultrastruct Pathol; 2015 Apr; 39(2):135-46. PubMed ID: 25350271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
    Abdou AG; Eldien MM; Elsakka D
    Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dermal stem cell factor and c-kit are overexpressed in melasma.
    Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
    Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
    Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
    Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of reflectance confocal microscopy in the diagnosis and management of pigmentary disorders: A review.
    Farabi B; Khan S; Jamgochian M; Atak MF; Jain M; Rao BK
    J Cosmet Dermatol; 2023 Dec; 22(12):3213-3222. PubMed ID: 37759421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
    Suiqing C; Min Z; Lirong C
    J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
    Reichrath J; Rass K
    Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common pigmentation disorders.
    Plensdorf S; Martinez J
    Am Fam Physician; 2009 Jan; 79(2):109-16. PubMed ID: 19178061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lasers.
    Passeron T
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S159-65. PubMed ID: 23522632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumours.
    Takahashi H; Saitoh K; Kishi H; Parsons PG
    Virchows Arch; 1995; 427(3):283-8. PubMed ID: 7496598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer.
    Lee JH; Pyon JK; Lee SH; Lee YJ; Kang SG; Kim CH; Kim DW; Nam HS; Park YH; Jeong DJ; Cho MK
    Int J Dermatol; 2011 Aug; 50(8):956-60. PubMed ID: 21781067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.